Combined Effect of Factor V Leiden and Prothrombin 20210A on the Risk of Venous Thromboembolism

Frits R. Rosendaal(Leiden University Medical Center), Joseph Emmerich(Délégation Paris 5), Jean‐Luc Reny(University Hospital of Geneva), Valerio De Stefano(Agostino Gemelli University Polyclinic), Tony Cumming(Université Claude Bernard Lyon 1), Valder R. Arruda(Children's Hospital of Philadelphia), Marco Cattaneo(University of Milan), Maurizio Margaglione(University of Foggia), Andreas Hillarp(Lund University)
Thrombosis and Haemostasis
January 1, 2001
10.1055/s-0037-1616136
Cited by 235

Related Papers

Incidence and mortality of venous thrombosis: a population‐based study
|Journal of Thrombosis and Haemostasis|2007|1.4k
Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study
|The Lancet|2011|1.3k
Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
|The Lancet|1994|1.1k
Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
|New England Journal of Medicine|1996|1.1k
Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis.
|PubMed|2001|803